Is restless legs syndrome underrecognized? Current management.

[1]  E. Lainey,et al.  Ropinirole in the treatment of restless legs syndrome: results from the TREAT RLS 1 study, a 12 week, randomised, placebo controlled study in 10 European countries. , 2009, Journal of neurology, neurosurgery, and psychiatry.

[2]  A. Walters,et al.  Ropinirole is effective in the treatment of restless legs syndrome. TREAT RLS 2: A 12‐week, double‐blind, randomized, parallel‐group, placebo‐controlled study , 2004, Movement disorders : official journal of the Movement Disorder Society.

[3]  W. Hening,et al.  The clinical neurophysiology of the restless legs syndrome and periodic limb movements. Part I: diagnosis, assessment, and characterization , 2004, Clinical Neurophysiology.

[4]  W. Paulus,et al.  Why do restless legs occur at rest?—pathophysiology of neuronal structures in RLS. Neurophysiology of RLS (part 2) , 2004, Clinical Neurophysiology.

[5]  C. Kushida,et al.  Ropinirole decreases periodic leg movements and improves sleep parameters in patients with restless legs syndrome. , 2004, Sleep.

[6]  P. Derambure,et al.  Prise en charge des impatiences et des mouvements périodiques au cours du sommeil , 2004 .

[7]  L. Ferini-Strambi,et al.  Epidemiology and clinical findings of restless legs syndrome. , 2004, Sleep medicine.

[8]  Richard P Allen,et al.  Impact, diagnosis and treatment of restless legs syndrome (RLS) in a primary care population: the REST (RLS epidemiology, symptoms, and treatment) primary care study. , 2004, Sleep medicine.

[9]  C. Adler,et al.  Ropinirole for restless legs syndrome , 2004, Neurology.

[10]  U. John,et al.  Sex and the risk of restless legs syndrome in the general population. , 2004, Archives of internal medicine.

[11]  P. Abom,et al.  Carbamazepine in restless legs , 1983, European Journal of Clinical Pharmacology.

[12]  B. Saletu,et al.  Gabapentin versus Ropinirole in the Treatment of Idiopathic Restless Legs Syndrome , 2003, Neuropsychobiology.

[13]  Richard P Allen,et al.  Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. , 2003, Sleep medicine.

[14]  D. Garcia-Borreguero,et al.  Treatment of restless legs syndrome with gabapentin: A double-blind, cross-over study , 2002, Neurology.

[15]  A. Walters.  Review of receptor agonist and antagonist studies relevant to the opiate system in restless legs syndrome. , 2002, Sleep medicine.

[16]  C. Comella.  Restless legs syndrome: Treatment with dopaminergic agents , 2002, Neurology.

[17]  A. Walters,et al.  Long‐Term follow‐up on restless legs syndrome patients treated with opioids , 2001, Movement disorders : official journal of the Movement Disorder Society.

[18]  T. Young,et al.  Epidemiology of restless legs symptoms in adults. , 2000, Archives of internal medicine.

[19]  J. Winkelmann,et al.  Aetiology and Treatment of Restless Legs Syndrome , 1999 .

[20]  S. Chokroverty,et al.  Positron emission tomographic studies in restless legs syndrome , 1999, Movement disorders : official journal of the Movement Disorder Society.

[21]  W. Oertel,et al.  A controlled study of additional sr-l-dopa in l-dopa–responsive restless legs syndrome with late-night symptoms , 1999, Neurology.

[22]  W. Ondo,et al.  Ropinirole for restless legs syndrome , 1999, Movement disorders : official journal of the Movement Disorder Society.

[23]  S. Perrot,et al.  Utilisation de la morphine dans les douleurs rhumatologiques non cancéreuses : les recommandations de Limoges , 1999 .

[24]  C Trenkwalder,et al.  Cerebral generators involved in the pathogenesis of the restless legs syndrome , 1997, Annals of neurology.

[25]  C. Adler.  Treatment of restless legs syndrome with gabapentin. , 1997, Clinical neuropharmacology.

[26]  C Trenkwalder,et al.  Periodic limb movements and restless legs syndrome. , 1996, Neurologic clinics.

[27]  M. Yunus,et al.  Restless legs syndrome and leg cramps in fibromyalgia syndrome: a controlled study , 1996, BMJ.

[28]  W. Oertel,et al.  L-dopa therapy of uremic and idiopathic restless legs syndrome: a double-blind, crossover trial. , 1995, Sleep.

[29]  Christopher Earley,et al.  Toward a better definition of the restless legs syndrome , 1995, Movement disorders : official journal of the Movement Disorder Society.

[30]  G. Lavigne,et al.  Restless legs syndrome and sleep bruxism: prevalence and association among Canadians. , 1994, Sleep.

[31]  K. Mills,et al.  A clinical, serological and neurophysiological study of restless legs syndrome in rheumatoid arthritis. , 1994, British Journal of Rheumatology.

[32]  R. Allen,et al.  A double-blind, placebo-controlled study of the treatment of periodic limb movements in sleep using carbidopa/levodopa and propoxyphene. , 1993, Sleep.

[33]  S. Chokroverty,et al.  Successful treatment of the idiopathic restless legs syndrome in a randomized double-blind trial of oxycodone versus placebo. , 1993, Sleep.

[34]  R. Godbout,et al.  Restless legs syndrome and periodic leg movements in sleep: the primary role of dopaminergic mechanism. , 1991, European neurology.

[35]  R. Godbout,et al.  Treatment of restless legs syndrome and periodic movements during sleep with , 1988, Neurology.

[36]  W. Gibb,et al.  The restless legs syndrome. , 1986, Postgraduate medical journal.

[37]  H. Pall,et al.  Restless leg syndrome and rheumatoid arthritis. , 1986, British medical journal.

[38]  W. Telstad,et al.  Treatment of the restless legs syndrome with carbamazepine: a double blind study. , 1984, British medical journal.